Top-line results from Lymphoseek NEO3-09 Phase 3 study in breast cancer, melanoma

[News]

Neoprobe Corporation, a diversified developer of innovative oncology diagnostic products, today announced top-line results from its Lymphoseek NEO3-09 study.

More... (http://www.news-medical.net/news/20110504/Top-line-results-from-Lymphoseek-NEO3-09-Phase-3-study-in-breast-cancer-melanoma.aspx)